Clinical Features and Treatment of 2019-nCov Pneumonia Patients in Wuhan: Report of A Couple Cases.

Zhan Zhang, Xiaochen Li, Wei Zhang, Zheng-Li Shi, Zhishui Zheng, Tao Wang
Author Information
  1. Zhan Zhang: Department of Respiratory Disease and Intensive Care, Renmin Hospital of Wuhan University, Wuhan, 430060, China. doctorzhang2003@163.com. ORCID
  2. Xiaochen Li: Department of Respiratory Disease and Intensive Care, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
  3. Wei Zhang: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China.
  4. Zheng-Li Shi: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China.
  5. Zhishui Zheng: Department of Respiratory Disease and Intensive Care, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
  6. Tao Wang: Department of Respiratory Disease and Intensive Care, Renmin Hospital of Wuhan University, Wuhan, 430060, China.

Abstract

No abstract text available.

References

  1. Zhonghua Nei Ke Za Zhi. 2004 Jun;43(6):406-9 [PMID: 15312430]
  2. Curr Top Microbiol Immunol. 2016;395:37-61 [PMID: 26305047]
  3. Virol Sin. 2018 Feb;33(1):104-107 [PMID: 29500691]
  4. J Innate Immun. 2020;12(1):4-20 [PMID: 31610541]

MeSH Term

Betacoronavirus
COVID-19
Coronavirus
Coronavirus Infections
Humans
Immune Evasion
Pandemics
Pneumonia, Viral
RNA
SARS-CoV-2

Chemicals

RNA